Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Indivior Pharmaceuticals Inc. (INDV) had Cost of Goods Sold of $66.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$358.00M |
|
$102.00M |
|
|
Cost of Goods Sold |
$66.00M |
$292.00M |
|
$276.00M |
|
$82.00M |
|
-- |
|
$81.00M |
|
$81.00M |
|
$102.00M |
|
$102.00M |
|
$102.00M |
|
$102.00M |
|
$82.00M |
|
-- |
|
124.39M |
|
130.00M |
|
$0.82 |
|
$0.79 |
|
| Balance Sheet Financials | |
$652.00M |
|
$144.00M |
|
$550.00M |
|
$1.20B |
|
$914.00M |
|
$290.00M |
|
$385.00M |
|
$1.30B |
|
$-99.00M |
|
$-101.00M |
|
$-98.00M |
|
125.00M |
|
| Cash Flow Statement Financials | |
$-27.00M |
|
$-66.00M |
|
$-30.00M |
|
$319.00M |
|
$195.00M |
|
$-124.00M |
|
$26.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|